| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |